Table 3.
Clinical evaluation of Achilles tendinopathy (values are presented as mean).
| Patient | NRS before | NRS after | VISA-A before | VISA-A after | VISA-A F.U. 12 months |
VISA-A F.U. 24 months |
|---|---|---|---|---|---|---|
| SL | 5 | 0 | 31 | 90 | 82 | 80 |
| MF | 7 | 1 | 33 | 84 | 89 | 81 |
| GG | 6 | 2 | 73 | 93 | 91 | 85 |
| SP | 5 | 0 | 69 | 87 | 87 | 86 |
| MML | 7 | 1 | 70 | 92 | 85 | 88 |
| MF | 8 | 2 | 35 | 85 | 81 | 89 |
| BR | 5 | 0 | 85 | 89 | 88 | 84 |
| NP | 6 | 1 | 46 | 86 | 87 | 80 |
| BM | 5 | 0 | 32 | 94 | 88 | 89 |
| CG | 6 | 0 | 64 | 92 | 89 | 88 |
| CD | 5 | 0 | 62 | 90 | 89 | 88 |
| IGA | 5 | 0 | 22 | 83 | 81 | — |
| PG | 7 | 2 | 43 | 89 | 85 | 85 |
| CR | 7 | 0 | 72 | 90 | 86 | 85 |